Inhibition of CXCL12/CXCR4 suppresses pulmonary arterial smooth muscle cell proliferation and cell cycle progression via PI3K/Akt pathway under hypoxia

References

• Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet 2003;361:1533–44
   PubMed Web of Science ®Google Scholar
• Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004;351:1425–36
   PubMed Web of Science ®Google Scholar
• Stenmark R, Fagan K, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ Res 2006;99:675–91
   PubMed Web of Science ®Google Scholar
• Jeffery TK, Wanstall JC. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther 2001;92:1–20
   PubMed Web of Science ®Google Scholar
• Pak O, Aldashev A, Welsh D, Peacock A. The effects of hypoxia on the cells of the pulmonary vasculature. Eur Respir J 2007;30:364–72
   PubMed Web of Science ®Google Scholar
• Ramchandran R, Pilipenko E, Bach L, et al. Hypoxic regulation of pulmonary vascular smooth muscle cyclic guanosine monophosphate-dependent kinase by the ubiquitin conjugating system. Am J Respir Cell Mol Biol 2012;46:323–30
   PubMed Web of Science ®Google Scholar
• Schober A. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 2008;28:1950–9
   PubMed Web of Science ®Google Scholar
• Nemenoff RA, Simpson PA, Furgeson SB, et al. Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha. Circ Res 2008;102:1036–45
   PubMed Web of Science ®Google Scholar
• Mirshahi F, Pourtau J, Li H, et al. SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models. Thromb Res 2000;99:587–94
   PubMed Web of Science ®Google Scholar
• Zernecke A, Schober A, Bot I, et al. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res 2005;96:784–91
   PubMed Web of Science ®Google Scholar
• Toshner M, Voswinckel R, Southwood M, et al. Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. Am J Respir Crit Care Med 2009;180:780–7
   PubMed Web of Science ®Google Scholar
• Dahal BK, Heuchel R, Pullamsetti SS, et al. Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-β. Pulm Circ 2011;1:259–68
   Google Scholar
• Young KC, Torres E, Hatzistergos KE, et al. Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxia-induced pulmonary hypertension. Circ Res 2009;104:1293–301
   PubMed Web of Science ®Google Scholar
• Gambaryan N, Perros F, Montani D, et al. Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension. Eur Respir J 2011;37:1392–9
   PubMed Web of Science ®Google Scholar
• Yu L, Hales CA. Effect of chemokine receptor CXCR4 on hypoxia-induced pulmonary hypertension and vascular remodeling in rats. Respir Res 2011;12:21
   PubMedGoogle Scholar
• Chan TO, Rittenhouse SE, Tsichlis PN. Akt/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem 1999;68:965–1014
   PubMed Web of Science ®Google Scholar
• Li Q, Zhu GD. Targeting serine/threonine protein kinase B/Akt and cell-cycle checkpoint kinases for treating cancer. Curr Top Med Chem 2002;2:939–71
   PubMedGoogle Scholar
• Li Y, Song YH, Mohler J, Delafontaine P. ANG II induces apoptosis of human vascular smooth muscle via extrinsic pathway involving inhibition of Akt phosphorylation and increased FasL expression. Am J Physiol Heart Circ Physiol 2006;290:H2116–23
   PubMed Web of Science ®Google Scholar
• Lee JH, Ragolia L. AKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cells. Am J Physiol Cell Physiol 2006;291:C1355–65
   PubMed Web of Science ®Google Scholar
• Bonnet S, Paulin R, Sutendra G, et al. Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axis. Circulation 2009;120:1231–40
   PubMed Web of Science ®Google Scholar
• Chiou WF, Chen CC, Wei BL. 3,4-Di-O-Caffeoylquinic acid inhibits angiotensin-ii-induced vascular smooth muscle cell proliferation and migration by downregulating the JNK and PI3K/Akt signaling pathways. Evid Based Complement Alternat Med 2011:634502
   Google Scholar
• Garat CV, Crossno JT Jr, Sullivan TM, et al. Inhibition of phosphatidylinositol-3-kinase/akt signaling attenuates hypoxia-induced pulmonary artery remodeling and suppresses CREB depletion in arterial smooth muscle cells. J Cardiovasc Pharmacol 2013;62:539–48
   PubMed Web of Science ®Google Scholar
• Jie W, Wang X, Zhang Y, et al. SDF-1α/CXCR4 axis is involved in glucose-potentiated proliferation and chemotaxis in rat vascular smooth muscle cells. Int J Exp Pathol 2010;91:436–44
   PubMed Web of Science ®Google Scholar
• Zhu D, Medhora M, Campbell WB, et al. Chronic hypoxia activates lung 15-lipoxygenase, which catalyzes production of 15-HETE and enhances constriction in neonatal rabbit pulmonary arteries. Circ Res 2003;92:992–1000
   PubMed Web of Science ®Google Scholar
• Guo L, Tang X, Tian H, et al. Subacute hypoxia suppresses Kv3.4 channel expression and whole-cell K+ currents through endogenous 15-hydroxyeicosatetraenoic acid in pulmonary arterial smooth muscle cells. Eur J Pharmacol 2008;587:187–95
   PubMed Web of Science ®Google Scholar
• Li Y, Li Q, Wang Z, et al. 15-HETE suppresses K(+) channel activity and inhibits apoptosis in pulmonary artery smooth muscle cells. Apoptosis 2009;14:42–51
   PubMed Web of Science ®Google Scholar
• Satoh K, Fukumoto Y, Nakano M, et al. Statin ameliorates hypoxia-induced pulmonary hypertension associated with down-regulated stromal cell-derived factor-1. Cardiovasc Res 2009;81:226–34
   PubMed Web of Science ®Google Scholar
• Karshovska E, Zagorac D, Zernecke A, et al. A small molecule CXCR4 antagonist inhibits neointima formation and smooth muscle progenitor cell mobilization after arterial injury. J Thromb Haemost 2008;6:1812–15
   PubMed Web of Science ®Google Scholar
• Nakano H, Namatame K, Nakayoshi A, Kumada K. The evaluation of cellular proliferating activity in gastric carcinoma with the proliferating cell nuclear antigen (PCNA) expressive rate: its fundamental examination of the immunohistochemical procedures and its clinical applications. Nihon Geka Gakkai Zasshi 1993;94:580–92
   PubMedGoogle Scholar
• Paterlini P, Suberville AM, Zindy F, et al. Cyclin A expression in human hematological malignancies: a new marker of cell proliferation. Cancer Res 1993;53:235–8
   PubMed Web of Science ®Google Scholar
• Barchiesi F, Jackson EK, Fingerle J, et al. 2-Methoxyestradiol, an estradiol metabolite, inhibits neointima formation and smooth muscle cell growth via double blockade of the cell cycle. Circ Res 2006;99:266–74
   PubMed Web of Science ®Google Scholar
• Ma C, Li Y, Ma J, et al. Key role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in pulmonary vascular remodeling and vascular angiogenesis associated with hypoxic pulmonary hypertension. Hypertension 2011;58:679–88
   PubMed Web of Science ®Google Scholar
• Lu X, Bijli KM, Ramirez A, et al. Hypoxia downregulates PPARγ via an ERK1/2-NF-κB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells. Free Radic Biol Med 2013;63:151–60
   PubMed Web of Science ®Google Scholar
• Wu X, Huang W, Luo G, Alain LA. Hypoxia induces connexin 43 dysregulation by modulating matrix metalloproteinases via MAPK signaling. Mol Cell Biochem 2013;384:155–62
   PubMed Web of Science ®Google Scholar